Case Reviews

Shockwave Reducer: Kunigunde’s Patient Story

Meet Kunigunde Grohmann, a 78-year-old female patient who is suffering from refractory angina despite a long history of cardiac procedures.

Kunigunde’s general practitioner referred her to Prof. Tommaso Gori (Univ. Medical Centre of Mainz, Germany), who chose Shockwave Reducer therapy to address her symptoms.

Testimonial

I’m glad I did this and I think it still helps me. Here at home I noticed that immediately and it was a relief to be able to walk again without stopping every five minutes.

Kunigunde Grohmann, Shockwave Reducer patient

Individual patient stories. Results may vary.

Shockwave Reducer is commercially available in select European countries and has been implanted in over 3,500 patients. It is currently under clinical investigation in the U.S.

CAUTION: In the United States, Shockwave Reducer is an investigational device, limited by United States law to investigational use. Shockwave Reducer is subject of investigational testing and is being studied in the COSIRA-II trial in Canada. Shockwave Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability. Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events: ifu.sw-reducer.com